Rexahn Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update Biotech Investing
Akebia Announces First Quarter 2016 Financial Results and Provides Corporate Update Biotech Investing
Mustang Bio Announces Oral Presentation of Initial Clinical Data for MB-101 (IL13Ra2-specific CAR T cells) by City of Hope Investigators at the American Society of Gene and Cell Therapy 19th Annual Meeting Biotech Investing
Dimension Therapeutics Announces Preclinical Data Supporting Ongoing DTX101 Phase 1/2 Clinical Trial at American Society for Gene and Cell Therapy (ASGCT) Annual Meeting Biotech Investing
KCR: Post-Authorization Study Develops Into Crucial Part of Drug Development Design Biotech Investing
